212Pb-PSMA-617

N/A

Report date: 2025/11/14 17:20:02

NME

Base Information

Drug Name212Pb-PSMA-617

Drug Alias Name212Pb-PSMA-617

ClassificationRadiation-emitting products > Nuclides > Lead > 212PbRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionProstate-Specific Membrane Antigen binders

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesARTBIO Inc

China Registration ClassN/A

Develop Information

Active CompaniesARTBIO Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms, Castration-Resistant

Inactive IndicationsN/A

Other Information

ATC CodeN/A